| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2147 | 2018 |
| A landscape of pharmacogenomic interactions in cancer F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ... Cell 166 (3), 740-754, 2016 | 1720 | 2016 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1683* | 2020 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1527 | 2014 |
| Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 987 | 2015 |
| Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ... Nature genetics 47 (2), 106-114, 2015 | 921 | 2015 |
| IntOGen-mutations identifies cancer drivers across tumor types A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ... Nature methods 10 (11), 1081-1082, 2013 | 573 | 2013 |
| CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer M Griffith, NC Spies, K Krysiak, JF McMichael, AC Coffman, AM Danos, ... Nature genetics 49 (2), 170-174, 2017 | 534 | 2017 |
| Comprehensive identification of mutational cancer driver genes across 12 tumor types D Tamborero, A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, ... Scientific reports 3 (1), 2650, 2013 | 534 | 2013 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 505 | 2020 |
| Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation A Berruezo, D Tamborero, L Mont, B Benito, JM Tolosana, M Sitges, ... European heart journal 28 (7), 836-841, 2007 | 486 | 2007 |
| Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ... Genome medicine 10, 1-8, 2018 | 472 | 2018 |
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes D Tamborero, A Gonzalez-Perez, N Lopez-Bigas Bioinformatics 29 (18), 2238-2244, 2013 | 451 | 2013 |
| Gender differences in clinical manifestations of Brugada syndrome B Benito, A Sarkozy, L Mont, S Henkens, A Berruezo, D Tamborero, ... Journal of the American College of Cardiology 52 (19), 1567-1573, 2008 | 350 | 2008 |
| Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals L Mont, D Tamborero, R Elosua, I Molina, B Coll-Vinent, M Sitges, B Vidal, ... Europace 10 (1), 15-20, 2008 | 336 | 2008 |
| In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities C Rubio-Perez, D Tamborero, MP Schroeder, AA Antolín, J Deu-Pons, ... Cancer cell 27 (3), 382-396, 2015 | 334 | 2015 |
| A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations D Tamborero, C Rubio-Perez, F Muiños, R Sabarinathan, JM Piulats, ... Clinical Cancer Research 24 (15), 3717-3728, 2018 | 264 | 2018 |
| Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia PG Ferreira, P Jares, D Rico, G Gómez-López, A Martínez-Trillos, ... Genome research 24 (2), 212-226, 2014 | 250 | 2014 |
| Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients M Matiello, M Nadal, D Tamborero, A Berruezo, J Montserrat, C Embid, ... Europace 12 (8), 1084-1089, 2010 | 204 | 2010 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martín-García, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 181 | 2018 |
